Search

Find exactly what you’re looking for.

Showing 61-80 of 239 results

On November 15, 2023, Matt Kohel will be speaking at the Maryland State Bar Association Business Law & Technology: What Transactional Lawyers Need to Know About AI and Cybersecurity event, as part of MSBA Legal Excellence Week. Matt's topic on which he will be speaking is "Cybersecurity, Data...

In an age where technology permeates nearly every facet of business, the importance of having a general understanding of Information Technology (IT) contracts is crucial.

Matthew Kohel, a partner in Saul Ewing's Litigation Department, hosted a webinar discussing the implementation of best practices and responsible use policies to manage the risk of utilizing AI in the workplace. The presentation focused on the identification and management of risks that can arise...

On Halloween, the U.S. Department of Health and Human Services (HHS), Office for Civil Rights (OCR) announced a $100,000 settlement under the Health Insurance Portability and Accountability Act (HIPAA) with Doctors’ Management Services (DMS), a Massachusetts medical management company that provides...

On Monday, October 30, President Biden issued the Executive Order on the Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence” [1] (the “Order”) in an attempt to seize the promise and manage the risks of artificial intelligence (“AI”) technology. The Order establishes new...

On October 11, the Department of Justice released a settlement agreement it entered into with a large, Florida-based automotive management company for False Claims Act violations based on an allegedly improper forgiveness of a Paycheck Protection Program loan. Up to now, the DOJ has primarily...

A perennial debate exists in the white-collar space: do the benefits of self-disclosure outweigh the risks associated with providing the government with a road map to the company’s purported violation? Consistently, the Department of Justice, among other government agencies, has answered that...

PCI, in partnership with Penn Medicine, is pleased to co-host a commercialization speaker series geared toward Penn Medicine faculty, researchers and students. Each session will feature an expert guest speaker as well as time for questions and discussion. The first session will discuss the latest...

For More Information